BM
Meyer, Benjamin
Affiliation entities
Research groups
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugates | Proceedings of the National Academy of Sciences of the United States of America | 2025 | 42 | 20 | |||
One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | 2024 | 41 | 61 | |||
SARS-CoV-2 viral load and shedding kinetics | Nature reviews. Microbiology | 2023 | 188 | 91 | |||
Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus | PloS one | 2023 | 92 | 31 | |||
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | 2023 | 92 | 111 | |||
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 176 | 33 | |||
Influence of circadian clocks on adaptive immunity and vaccination responses | Nature communications | 2023 | 275 | 62 | |||
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 149 | 112 | |||
Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva | Epidemics | 2022 | 176 | 68 | |||
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | 2022 | 102 | 27 | |||
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 73 | 0 | |||
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | 2022 | 1,419 | 197 | |||
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 407 | 106 | |||
COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 116 | 81 | |||
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 261 | 137 | |||
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | 2022 | 248 | 81 | |||
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 176 | 122 | |||
Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 402 | 141 | |||
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 335 | 38 | |||
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 398 | 211 | |||
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 498 | 287 | |||
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 275 | 103 | |||
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study | Infection Control and Hospital Epidemiology | 2021 | 293 | 172 | |||
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 277 | 228 | |||
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 368 | 181 | |||
Waning antibodies to SARS-CoV-2 - Don't panic | The Lancet Regional Health. Europe | 2021 | 155 | 65 | |||
Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana | One Health Outlook | 2021 | 234 | 88 | |||
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 383 | 235 | |||
A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | 2021 | 288 | 172 | |||
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | 2021 | 616 | 123 | |||
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 317 | 145 | |||
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | 2020 | 426 | 156 | |||
Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | 2020 | 490 | 268 | |||
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 740 | 14 | |||
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 425 | 349 | |||
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 360 | 172 | |||
SARS-CoV-2 seroprevalence in COVID-19 hotspots | The Lancet | 2020 | 332 | 92 | |||
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 498 | 186 | |||
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | 2020 | 240 | 99 | |||
Link of a ubiquitous human coronavirus to dromedary camels | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 194 | 104 |